Gorin E, Goodman H M
Endocrinology. 1985 May;116(5):1796-805. doi: 10.1210/endo-116-5-1796.
Adipocytes isolated from the epididymal fat pads of normal rats specifically bound [125I]human GH [( 125I]hGH). Preincubation of cells with 20 micrograms/ml cycloheximide, an inhibitor of protein synthesis, produced a progressive loss of ability to bind [125I]hGH specifically. Loss of binding sites with time followed first order kinetics and had a half-time of about 45 min regardless of whether GH was present or absent during treatment with cycloheximide. Nonspecific binding of labeled hormone was unchanged by cycloheximide. Similar results were obtained when adipocytes were incubated with 200 micrograms/ml puromycin, another inhibitor of translation, but incubation with 5 micrograms/ml actinomycin D, an inhibitor of transcription, for 2.5 h had no effect on the binding of [125I]hGH by adipocytes. The findings are not attributable to cell death, since oxidation of [U-14C] glucose to 14CO2 and binding of [125I]insulin were unaffected in replicate cell populations exposed to the same treatments. Diminished binding could not be attributed to an effect of cycloheximide to hasten the degradation of receptor-bound hGH. Treatment of adipocytes with 0.1 mg/ml trypsin for 10 min virtually abolished their ability to bind [125I]hGH specifically, but binding capability gradually returned after removal of trypsin and was nearly restored to pretrypsin levels by 2 h. Addition of cycloheximide to the incubation medium after removal of trypsin completely prevented recovery of binding capability. Covalent binding of [125I]hGH to its receptors with disuccinimidyl suberate followed by sodium dodecyl sulfate-gel electrophoresis and autoradiography of proteins isolated from adipocyte membranes revealed three specifically labeled bands corresponding to mol wt of 250-300, 130, and 56 kilodaltons. Treatment of adipocytes with cycloheximide before cross-linking resulted in a proportional reduction in all three labeled bands, suggesting a similar half-life for all three entities. Similarly, all three labeled entities reappeared in parallel as adipocytes recovered from treatment with trypsin. The data strongly suggest that receptors for GH turn over rapidly on the surface of adipocytes and that ongoing protein synthesis is required to maintain binding capacity. The data do not permit distinction between rapid turnover of the receptor proteins themselves and a short-lived protein(s) which might be required to insert the receptors into the membrane.
从正常大鼠附睾脂肪垫分离出的脂肪细胞能特异性结合[125I]人生长激素([125I]hGH)。用20微克/毫升环己酰亚胺(一种蛋白质合成抑制剂)对细胞进行预孵育,会导致特异性结合[125I]hGH的能力逐渐丧失。结合位点随时间的丧失遵循一级动力学,无论在用环己酰亚胺处理期间生长激素是否存在,半衰期约为45分钟。环己酰亚胺对标记激素的非特异性结合没有影响。当脂肪细胞与200微克/毫升嘌呤霉素(另一种翻译抑制剂)孵育时,也得到了类似的结果,但与5微克/毫升放线菌素D(一种转录抑制剂)孵育2.5小时对脂肪细胞结合[125I]hGH没有影响。这些发现并非由于细胞死亡,因为在接受相同处理的重复细胞群体中,[U-14C]葡萄糖氧化为14CO2以及[125I]胰岛素的结合不受影响。结合能力的降低不能归因于环己酰亚胺加速受体结合的hGH降解的作用。用0.1毫克/毫升胰蛋白酶处理脂肪细胞10分钟,实际上消除了它们特异性结合[125I]hGH的能力,但去除胰蛋白酶后结合能力逐渐恢复,到2小时时几乎恢复到胰蛋白酶处理前的水平。去除胰蛋白酶后,在孵育培养基中加入环己酰亚胺完全阻止了结合能力的恢复。用辛二酸二琥珀酰亚胺酯使[125I]hGH与其受体共价结合,随后进行十二烷基硫酸钠 - 凝胶电泳以及对从脂肪细胞膜分离的蛋白质进行放射自显影,结果显示有三条特异性标记带,其对应的分子量分别为250 - 300、130和56千道尔顿。在交联前用环己酰亚胺处理脂肪细胞,导致所有三条标记带成比例减少,这表明这三个实体具有相似的半衰期。同样,当脂肪细胞从胰蛋白酶处理中恢复时,所有三个标记实体同时重新出现。数据强烈表明,生长激素受体在脂肪细胞表面快速周转,并且持续的蛋白质合成是维持结合能力所必需的。这些数据无法区分受体蛋白本身的快速周转和可能需要将受体插入膜中的短寿命蛋白质。